Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cetrorelix Pamoate (AEZS-102) in Patients With Symptomatic BPH: an Open-Labeled Safety and Efficacy Assessment Study

NCT00670306 is registered in ClinicalTrials.gov with AEterna Zentaris as lead sponsor.

NCT NCT00670306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00670306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cetrorelix Pamoate (AEZS-102) in Patients With Symptomatic BPH: an Open-Labeled Safety and Efficacy Assessment Study
Lead sponsor
AEterna Zentaris
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2008
Completion date
August 31, 2009
Enrollment
528 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hypertrophy